Gregorio Cordini
General San Martin, B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Rituximab Binding Endows CD20+ Extracellular Vesicles With NK Cell-Activating Properties in B Cell Lymphoma.
Journal: Journal of extracellular vesicles
Published: January 14, 2026
Single-Cell Morphometrics From Hematoxylin and Eosin-Stained Images Reveals Subtype-Specific Features in Chronic Lymphocytic Leukemia.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: September 04, 2025
Single-Cell Morphometrics From Hematoxylin and Eosin-Stained Images Reveals Subtype-Specific Features in Chronic Lymphocytic Leukemia.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: September 04, 2025
Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia.
Journal: Frontiers in oncology
Published: January 13, 2023
Subendocardial injury with no evidence of atherosclerosis associated with obinutuzumab infusion
Journal: Medicina
Published: December 07, 2021
Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype.
Journal: Cancer immunology, immunotherapy : CII
Published: February 08, 2021
Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia.
Journal: Scientific reports
Published: November 13, 2020
In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia.
Journal: Frontiers in oncology
Published: August 24, 2020
The effect of ibrutinib on neutrophil and γδ T cell functions.
Journal: Leukemia & lymphoma
Published: April 21, 2020
Second generation BTK inhibitors impair the anti-fungal response of macrophages and neutrophils.
Journal: American journal of hematology
Published: January 29, 2020
Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.
Journal: Haematologica
Published: May 12, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026